의약품 및 바이오테크놀러지 분야의 공동 개발 계약(2016-2026년)

Power Smarter Partnerships: Explore Co-development Models, Terms, and Dealmakers Across the Global Biopharma Landscape

The Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 report delivers the most comprehensive analysis of collaborative development agreements in the life sciences sector. Spanning nearly a decade of activity, the report provides a data-rich view into how companies co-develop drug candidates, share development risk, and align commercialization responsibilities.

This fully updated edition explores real-world co-development deals and includes financial terms, partnering strategies, and links to actual SEC-filed contract documents where available.

Free report sample

Key Features & Benefits

• Covers Deals from 2016 to 2026

Track the evolution of co-development dealmaking and identify strategic patterns.

• Analyze Deal Structures and Terms

Understand how co-development deals are structured-who contributes what, how risks are shared, and how profits are split.

• Benchmark Financials with Confidence

Review headline values, milestone payments, and equity contributions to support your own deal modeling.

• Access Real Contract Language

Where available, examine actual contract filings to gain insight into deal clauses, definitions, and triggers.

• Spot the Most Active Players

Identify the top 25 companies engaging in co-development deals-and learn what differentiates their approach.

What's Inside - Chapter Breakdown

Chapter 1: Introduction

An overview of co-development dealmaking, why companies choose this model, and how this report is structured.

Chapter 2: Trends in Co-development Activity

Visual and narrative analysis of co-development deals by year, sector, therapeutic area, and region.

Chapter 3: Deal Structures & Key Clauses

Breaks down how companies share IP, development responsibilities, costs, and commercialization rights.

Chapter 4: High-Value Co-development Deals

Profiles of major deals sorted by disclosed value. Includes financial terms, strategic rationale, and links to original contracts where publicly available.

Chapter 5: Top 25 Active Co-development Dealmakers

Company profiles with deal histories and partnership approaches-including links to each company's full deal records.

Chapter 6: Comprehensive Deal Directory

Detailed index of co-development deals organized by:

• Company A-Z
• Therapy area
• Technology type
• Deal type
• Each record links to the Current Agreements database, with contract documents where available.
• Who Should Use This Report?
• Business Development & Licensing Professionals - Evaluate structures, terms, and partner roles across successful deals.
• C-Level Executives & Investors - Understand how collaborative development can accelerate product pipelines and reduce burn.
• Legal & Contract Managers - Benchmark real-world clauses and deal mechanics to guide your own term sheets.
• Commercial & Strategic Planners - Learn how rights, responsibilities, and revenues are allocated across co-development partners.
• Why This Report Matters
• As development costs rise and timelines tighten, co-development deals offer a compelling solution-shared risk, aligned incentives, and faster execution. This report helps you understand what's market standard, what's negotiable, and what leading companies are doing to succeed in shared R&D partnerships.
• Learn from real deals. See how the leaders collaborate. Build stronger partnerships. Order your copy of Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 today.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-development dealmaking

• 2.1. Introduction
• 2.2. Definition of co-development deal
• 2.3. Trends in co-development deals since 2016
  • 2.3.1. Co-development dealmaking by year, 2016-2026
  • 2.3.2. Co-development dealmaking by phase of development, 2016-2026
  • 2.3.3. Co-development dealmaking by industry sector, 2016-2026
  • 2.3.4. Co-development dealmaking by therapy area, 2016-2026
  • 2.3.5. Co-development dealmaking by technology type, 2016-2026
  • 2.3.6. Co-development dealmaking by most active company, 2016-2026
• 2.4. Reasons for entering into co-development partnering deals
• 2.5. The future of co-development deals

Chapter 3 - Overview of co-development deal structure

• 3.1. Introduction
• 3.2. Co-development agreement structure

Chapter 4 - Leading co-development deals

• 4.1. Introduction
• 4.2. Top co-development deals by value

Chapter 5 - Top 25 most active co-development dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-development dealmakers

Chapter 6 - Co-development deals including contracts directory

• 6.1. Introduction
• 6.2. Co-development deals with contracts 2016-2026
• Deal directory
• Deal directory - co-development dealmaking by companies A-Z
• Deal directory - co-development dealmaking by therapy area
• Deal directory - co-development dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-development deal
• Figure 2: Trends in co-development deal announcements, 2016-2026
• Figure 3: Co-development deals signed at each phase of development, 2016-2026
• Figure 4: Co-development deals by industry sector, 2016-2026
• Figure 5: Co-development deals by therapy area, 2016-2026
• Figure 6: Co-development deals by technology type, 2016-2026
• Figure 7: Top 25 most active co-development dealmakers, 2016-2026
• Figure 8: Top co-development deals by value, 2016-2026
• Figure 9: Most active co-development dealmakers, 2016-2026